KLK3 and prostate cancer: After initiation of pembrolizumab, his prostate-specific antigen level decreased, imaging findings showed good response with lymph node shrinkage, and his walking difficulty decreased dramatically.<h4>Conclusion</h4>The rarity of microsatellite instability-high tumor in castration-resistant prostate cancer may hamper pembrolizumab administration.